Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

TMCI holding history

Treace Medical Concepts, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TMCI overviewAll 13F holders of TMCIFull Q2 2026 holdings

Shares (Q2 2026)
366,445
Value
$1.46M
% of portfolio
<0.1%
Quarters held
21
Since Q2 2021
Holdings of TMCI by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026366,445$1.46M<0.1%−176,460−32.5%ReducedHolders
Q1 2026542,905$727.5K<0.1%+248,976+84.7%AddedHolders
Q4 2025293,929$720.1K<0.1%+10,580+3.7%AddedHolders
Q3 2025283,349$1.90M<0.1%−94,098−24.9%ReducedHolders
Q2 2025377,447$2.22M<0.1%+16,128+4.5%AddedHolders
Q1 2025361,319$3.03M<0.1%−607,115−62.7%ReducedHolders
Q4 2024968,434$7.21M<0.1%+892,456+1,174.6%AddedHolders
Q3 202475,978$440.7K<0.1%+35,959+89.9%AddedHolders
Q2 202440,019$266.1K<0.1%−44,684−52.8%ReducedHolders
Q1 202484,703$1.11M<0.1%+32,904+63.5%AddedHolders
Q4 202351,799$660.4K<0.1%+51,674+41,339.2%AddedHolders
Q3 2023125$1.64K<0.1%−33,199−99.6%ReducedHolders
Q2 202333,324$852.4K<0.1%+19,179+135.6%AddedHolders
Q1 202314,145$356.3K<0.1%+8,039+131.7%AddedHolders
Q4 20226,106$140.4K<0.1%+4,664+323.4%AddedHolders
Q3 20221,442$32.0K<0.1%+637+79.1%AddedHolders
Q2 2022805$11.0K<0.1%+705+705.0%AddedHolders
Q1 2022100$2.00K<0.1%−9,435−99.0%ReducedHolders
Q4 20219,535$178.0K<0.1%+9,311+4,156.7%AddedHolders
Q3 2021224$6.00K<0.1%−251−52.8%ReducedHolders
Q2 2021475$15.0K<0.1%+475NewHolders